Baiteng Zhao - 19 Dec 2024 Form 4 Insider Report for Aadi Bioscience, Inc. (WHWK)

Role: Director
Signature: /s/ Stephen Rodin, as Attorney-in-Fact
Issuer symbol: WHWK
Transactions as of: 19 Dec 2024
Net transactions value: $0
Form type: 4
Filing time: 23 Dec 2024, 17:36:13 UTC
Next filing: 04 Mar 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AADI	Stock Option (right to buy)	Award	$0	+61,192		$0.000000	61,192	19 Dec 2024	Common Stock	61,192	$2.32	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one-thirty-sixth (1/36th) of the shares subject to the option shall vest monthly following the Date of Grant on the same day of the month as the Date of Grant (and if there is no corresponding day, the last day of the month), such that the option will be fully vested and exercisable three (3) years from the Date of Grant. "Date of Grant" shall mean December 19, 2024.

Content

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one-thirty-sixth (1/36th) of the shares subject to the option shall vest monthly following the Date of Grant on the same day of the month as the Date of Grant (and if there is no corresponding day, the last day of the month), such that the option will be fully vested and exercisable three (3) years from the Date of Grant. "Date of Grant" shall mean December 19, 2024.